Mark Sabag - Jan 28, 2025 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Role
EVP, International Markets
Signature
/s/ Dov Bergwerk as attorney-in-fact for Mark Sabag
Stock symbol
TEVA
Transactions as of
Jan 28, 2025
Transactions value $
$0
Form type
4
Date filed
1/30/2025, 04:03 PM
Previous filing
Mar 7, 2024
Next filing
Feb 14, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TEVA Restricted Share Units Award $0 +183K $0.00 183K Jan 28, 2025 Ordinary Shares 183K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
F2 Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to time-based vesting and will vest on March 4, 2025.
F3 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.